Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling

BACKGROUND: Human mesenchymal stem cells (hMSCs) therapy has recently been considered a promising treatment for atopic dermatitis (AD) due to their immunomodulation and tissue regeneration ability. In our previous studies, we demonstrated that hMSCs alleviate allergic inflammation in murine AD model...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Nari, Jung, Namhee, Lee, Seung-Eun, Kong, Dasom, Kim, Nam Gyo, Kook, Myung Geun, Park, Hwanhee, Choi, Soon Won, Lee, Seunghee, Kang, Kyung-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399851/
https://www.ncbi.nlm.nih.gov/pubmed/34454603
http://dx.doi.org/10.1186/s13287-021-02547-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399851/
https://www.ncbi.nlm.nih.gov/pubmed/34454603
http://dx.doi.org/10.1186/s13287-021-02547-8

Ejemplares similares